Acadia Healthcare Announces CFO Resignation, Appoints Former CFO as Interim; Reaffirms Guidance
ACHC has more than doubled off its 52-week low of $11.43.
Summary
Acadia Healthcare announced the resignation of its CFO, Todd Young, and the appointment of former CFO David Duckworth as interim, while also reaffirming its Q1 and full-year 2026 financial guidance.
Key Events · Executive and Board Changes · ACHC
-
CFO Resignation
Todd Young will resign as Chief Financial Officer, effective April 30, 2026, to pursue another opportunity.
-
Interim CFO Appointment
David M. Duckworth, who previously served as Acadia's CFO from July 2012 to July 2023, has been appointed Interim Chief Financial Officer, effective May 1, 2026.
-
Financial Guidance Reaffirmed
The company reaffirmed its financial guidance for both the first quarter and full year 2026, as previously updated on February 25, 2026.
-
Interim CFO Compensation
Mr. Duckworth's employment agreement includes a base salary of $100,000 per month and a quarterly cash bonus of $125,000.
Analysis · ACHC · Industrial Applications And Services
The departure of a Chief Financial Officer is a significant executive change, introducing a degree of uncertainty. However, the appointment of David Duckworth, a former CFO with extensive company knowledge, as interim CFO helps to mitigate potential disruption. The simultaneous reaffirmation of the company's financial guidance for both the first quarter and full year 2026 provides a strong counter-signal, indicating operational stability despite the leadership transition. Investors should monitor the search for a permanent CFO and any future updates to guidance.
At the time of this filing, ACHC was trading at $27.29 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $2.5B. The 52-week trading range was $11.43 to $28.48. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.